Abstract
Publication details
- Journal
- Oman Medical Journal, 23(4)
- Publisher
- Oman Medical Specialty Board
- Open access
- Gold open access
- License
- CC BY-NC 4.0
Cite this article
APA 7
Wali, Y., Al Shidhani, A., & Daar, S. (2008). Agranulocyosis in Beta Thalassemia Major Patients treated with Oral Iron Chelating Agent (Deferiprone). Oman Medical Journal, 23(4). https://omanscience.com/en/articles/agranulocyosis-in-beta-thalassemia-major-patients-treated-with-oral-iron-chelating-agent-deferiprone
MLA 9
Wali, Yasser, et al. "Agranulocyosis in Beta Thalassemia Major Patients treated with Oral Iron Chelating Agent (Deferiprone)." Oman Medical Journal, vol. 23, no. 4, 2008. https://omanscience.com/en/articles/agranulocyosis-in-beta-thalassemia-major-patients-treated-with-oral-iron-chelating-agent-deferiprone.
Chicago (author–date)
Wali, Yasser, Azza Al Shidhani, and Shahina Daar. 2008. "Agranulocyosis in Beta Thalassemia Major Patients treated with Oral Iron Chelating Agent (Deferiprone)." Oman Medical Journal 23 (4). https://omanscience.com/en/articles/agranulocyosis-in-beta-thalassemia-major-patients-treated-with-oral-iron-chelating-agent-deferiprone.
Harvard
Wali, Y., Al Shidhani, A. and Daar, S. (2008) 'Agranulocyosis in Beta Thalassemia Major Patients treated with Oral Iron Chelating Agent (Deferiprone)', Oman Medical Journal, 23(4). Available at: https://omanscience.com/en/articles/agranulocyosis-in-beta-thalassemia-major-patients-treated-with-oral-iron-chelating-agent-deferiprone.
Vancouver
Wali Y, Al Shidhani A, Daar S. Agranulocyosis in Beta Thalassemia Major Patients treated with Oral Iron Chelating Agent (Deferiprone). Oman Medical Journal. 2008;23(4). https://omanscience.com/en/articles/agranulocyosis-in-beta-thalassemia-major-patients-treated-with-oral-iron-chelating-agent-deferiprone
IEEE
Y. Wali, A. Al Shidhani, and S. Daar, "Agranulocyosis in Beta Thalassemia Major Patients treated with Oral Iron Chelating Agent (Deferiprone)," Oman Medical Journal, vol. 23, no. 4, 2008, https://omanscience.com/en/articles/agranulocyosis-in-beta-thalassemia-major-patients-treated-with-oral-iron-chelating-agent-deferiprone.